Apyx Medical Corporation (APYX) |
| 3.86 -0.03 (-0.77%) 07-28 16:00 |
| Open: | 3.83 |
| High: | 3.91 |
| Low: | 3.78 |
| Volume: | 62,193 |
| Market Cap: | 163(M) |
| PE Ratio: | -17.55 |
| Exchange: | NASDAQ |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 4.87 |
| Resistance 1: | 4.45 |
| Pivot price: | 4.14 |
| Support 1: | 3.78 |
| Support 2: | 3.14 |
| 52w High: | 5.08 |
| 52w Low: | 1.59 |
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| EPS | -0.220 |
| Book Value | 0.310 |
| PEG Ratio | 0.59 |
| Gross Profit | 0.838 |
| Profit Margin (%) | -16.40 |
| Operating Margin (%) | -7.29 |
| Return on Assets (ttm) | -4.4 |
| Return on Equity (ttm) | -76.5 |
Tue, 28 Jul 2026
Apyx Medical Corp (APYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tue, 28 Jul 2026
Apyx Medical CEO and CFO to Hold Aug. 11 Investor Fireside Chat - Stock Titan
Tue, 28 Jul 2026
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference - Yahoo Finance
Mon, 27 Jul 2026
APYX|Apyx Medical Corp|Price:3.850|Chg%:-0.070 - TradingKey
Sat, 25 Jul 2026
Apyx Medical Corporation Revenue Breakdown – TRADEGATE:BOV - TradingView
Thu, 23 Jul 2026
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |